Overview on wearable sensors for the management of Parkinson's disease.

Autor: Moreau C; Department of Neurology, Parkinson's disease expert Center, Lille University, INSERM UMRS_1172, University Hospital Center, Lille, France.; The French Ns-Park Network, Paris, France., Rouaud T; The French Ns-Park Network, Paris, France.; CHU Nantes, Centre Expert Parkinson, Department of Neurology, Nantes, F-44093, France., Grabli D; The French Ns-Park Network, Paris, France.; Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Paris, France., Benatru I; The French Ns-Park Network, Paris, France.; Department of Neurology, University Hospital of Poitiers, Poitiers, France.; INSERM, CHU de Poitiers, University of Poitiers, Centre d'Investigation Clinique CIC1402, Poitiers, France., Remy P; The French Ns-Park Network, Paris, France.; Centre Expert Parkinson, NS-Park/FCRIN Network, CHU Henri Mondor, AP-HP, Equipe NPI, IMRB, INSERM et Faculté de Santé UPE-C, Créteil, FranceService de neurologie, hôpital Henri-Mondor, AP-HP, Créteil, France., Marques AR; The French Ns-Park Network, Paris, France.; Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, Clermont-Ferrand, France., Drapier S; The French Ns-Park Network, Paris, France.; Pontchaillou University Hospital, Department of Neurology, CIC INSERM 1414, Rennes, France., Mariani LL; The French Ns-Park Network, Paris, France.; Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Paris, France., Roze E; The French Ns-Park Network, Paris, France.; Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Paris, France., Devos D; The French Ns-Park Network, Paris, France.; Parkinson's Disease Centre of Excellence, Department of Medical Pharmacology, Univ. Lille, INSERM; CHU Lille, U1172 - Degenerative & Vascular Cognitive Disorders, LICEND, NS-Park Network, F-59000, Lille, France., Dupont G; The French Ns-Park Network, Paris, France.; Centre hospitalier universitaire François Mitterrand, Département de Neurologie, Université de Bourgogne, Dijon, France., Bereau M; The French Ns-Park Network, Paris, France.; Service de neurologie, université de Franche-Comté, CHRU de Besançon, 25030, Besançon, France., Fabbri M; The French Ns-Park Network, Paris, France. margheritafabbrimd@gmail.com.; Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Centre, NS-Park/FCRIN Network and NeuroToul COEN Center, Toulouse University Hospital, INSERM, University of Toulouse 3, Toulouse, France. margheritafabbrimd@gmail.com.
Jazyk: angličtina
Zdroj: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2023 Nov 02; Vol. 9 (1), pp. 153. Date of Electronic Publication: 2023 Nov 02.
DOI: 10.1038/s41531-023-00585-y
Abstrakt: Parkinson's disease (PD) is affecting about 1.2 million patients in Europe with a prevalence that is expected to have an exponential increment, in the next decades. This epidemiological evolution will be challenged by the low number of neurologists able to deliver expert care for PD. As PD is better recognized, there is an increasing demand from patients for rigorous control of their symptoms and for therapeutic education. In addition, the highly variable nature of symtoms between patients and the fluctuations within the same patient requires innovative tools to help doctors and patients monitor the disease in their usual living environment and adapt treatment in a more relevant way. Nowadays, there are various body-worn sensors (BWS) proposed to monitor parkinsonian clinical features, such as motor fluctuations, dyskinesia, tremor, bradykinesia, freezing of gait (FoG) or gait disturbances. BWS have been used as add-on tool for patients' management or research purpose. Here, we propose a practical anthology, summarizing the characteristics of the most used BWS for PD patients in Europe, focusing on their role as tools to improve treatment management. Consideration regarding the use of technology to monitor non-motor features is also included. BWS obviously offer new opportunities for improving management strategy in PD but their precise scope of use in daily routine care should be clarified.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: